Plasma Lectin Pathway Complement Proteins in Patients With COVID-19 and Renal Disease. (2021)

First Author: Medjeral-Thomas NR
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2021.671052

PubMed Identifier: 33995410

Publication URI: http://europepmc.org/abstract/MED/33995410

Type: Journal Article/Review

Volume: 12

Parent Publication: Frontiers in immunology

ISSN: 1664-3224